猪模型评估腔内组织减容系统治疗后的静脉解剖
本研究在猪髂静脉模型(13只动物26条静脉,含支架置入后静脉)中比较新型Recana血栓切除装置(RTD)与CLEANER、ClotTriever的安全性。结果显示无严重损伤或设备相关出血,RTD组组织学内膜损伤较CLEANER明显但与ClotTriever相似,支持进一步临床研究。
要点
- RTD在正常及支架置入后髂静脉中可接触腔内物质而无严重损伤。
- 组织学显示RTD内膜损伤较CLEANER明显但与ClotTriever相似。
- 无透壁撕裂或设备相关出血,支持推进首次临床试验。
核心结论
- 新型静脉组织减容系统在猪正常及支架置入后髂静脉模型中可接触腔内物质而不造成严重损伤。
- 静脉壁创伤与常用机械血栓切除装置相当,无透壁撕裂或设备相关出血。
研究设计与样本
- 在13只猪的26条髂静脉中研究RTD与CLEANER、ClotTriever的安全性比较。
- 正常静脉18条(9只动物),支架置入21天后的静脉8条(4只动物)。
- 每侧髂静脉均行10次器械通过,在5±2天或30±2天处死行组织学评估。
主要发现
- 所有动物存活至预定终点,无意外死亡。
- 1例股总静脉入路并发症导致单侧静脉周围血肿和血栓形成;另1只动物出现介入后静脉狭窄并最终闭塞。
- 其余24条髂静脉在尸检时保持通畅且无显著狭窄。
- 所有器械均见内膜撕裂和炎症,RTD较CLEANER更明显但与ClotTriever相似。
- 部分RTD病例出现轻度静脉周围瘀斑,无透壁出血证据。
临床怎么用
- 该装置在支架内再狭窄和原生血管闭塞模型中展示出可行性,支持推进首次临床试验。
- 研究提示需关注入路并发症及介入后静脉狭窄/闭塞风险。
局限性
- 为猪动物模型研究,结果向人体外推需谨慎。
- 样本量有限,各器械组静脉条数不等。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Residual venous obstruction and in-stent restenosis are common and challenging complications that may occur after interventional procedures performed for acute deep vein thrombosis or chronic iliofemoral venous obstruction. A novel fully integrated thrombectomy system [Recana Thrombectomy Device (RTD)] was designed to treat (in-stent restenosis) and native vessel obstructions. The system includes a debulking catheter, collection baskets, and a family of sheaths. This report describes its use in animal models of native and stented veins to assess safety compared with currently available thrombectomy devices. METHODS: The RTD was studied in comparison to two currently marketed thrombectomy devices, the Argon CLEANER 15 (CLEANER; Argon Medical Devices Inc.) and the Inari ClotTriever (ClotTriever Catheter; Inari Medical, Inc.). Devices were studied in a porcine iliac vein model used in a manner consistent with good laboratory practice for Nonclinical Laboratory Studies. A total of 26 iliac veins in 13 animals were studied to evaluate performance in normal veins (9 animals, 18 iliac veins) and in four animals with eight iliac veins pretreated with iliac stents implanted 21 days before device treatment. Twelve normal iliac veins were treated with the RTD, four normal veins were treated with CLEANER, and two with the ClotTriever. Five prestented iliac veins were treated with the RTD, and three prestented veins were treated with the CLEANER. Procedures were completed under fluoroscopic and intravascular ultrasound guidance. For each model, both iliac veins were treated with 10 passes of the test or control thrombectomy device through the length of the common and external iliac veins. Survival and sacrifice periods were completed at varied time points to evaluate peak histological injury potential, vein wall healing, and vein patency. Necropsy was performed at 5 ± 2 or 30 ± 2 days after catheter intervention for gross evaluation of the iliac veins and other related tissues. Histology was performed on representative sections of treated iliac veins to evaluate wall damage, thrombosis, or other effects of intervention. RESULTS: All animals survived to their designated end points with no unexpected mortality. One common femoral vein access complication led to unilateral perivenous hematoma and thrombosis. Another animal showed postintervention venous constriction with eventual vessel occlusion. All other iliac veins (n = 24) remained patent without significant stenosis at necropsy. No clinically relevant lacerations, perforations, or hemorrhagic events were observed with either the Test or Control devices. Histology revealed intimal disruption and inflammation with all devices, more pronounced with the RTD compared with CLEANER but similar to those seen after use of the ClotTriever. Mild perivenous bruising occurred in some Test device cases, without evidence of transmural bleeding. CONCLUSIONS: In an in vivo model of stented and native iliac veins, a novel venous tissue debulking system was able to engage intraluminal material without serious injury. Vein wall trauma was comparable to a commonly used mechanical thrombectomy device, with no transmural lacerations or device-related hemorrhage. These findings support continued development toward initial clinical trials in patients with venous obstruction. CLINICAL RELEVANCE: This experimental study utilizes a porcine model for examination of a novel venous thrombectomy device in normal and stented iliac veins. The study examines the degree of injury occurring within the vein wall in normal and stented iliac veins after treatment with the test device compared with currently marketed thrombectomy devices. The feasibility of removal of the material causing in-stent restenosis is established using the Test device. The study also provides key information on the response of the iliac vein wall in this model to intraluminal devices that impact the wall during treatment.
引用
- Marston W, Dooley E, Chinubhai A, et al. Evaluation of venous anatomy after treatment with an intraluminal tissue debulking system in a porcine model. J Vasc Surg Venous Lymphat Disord. 2026. PMID: 42556526. doi:10.1016/j.jvsv.2026.102595
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。